ORAMED PHARMACEUTICALS INC. Operating Leases, Future Minimum Payments, Due in Three Years
ORAMED PHARMACEUTICALS INC. (ORMP) had Operating Leases, Future Minimum Payments, Due in Three Years of $135.00 thousand as of 2021-02-28, per its 10-Q filed 2021-04-13.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2021-04-13
- 2014-05-31: Operating Leases, Future Minimum Payments, Due in Three Years 89.05K ILS.
- 2014-02-28: Operating Leases, Future Minimum Payments, Due in Three Years 89.05K ILS.
ILS
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2014-05-31 | 89.05K ILS 10-Q · filed 2014-07-14 |
| 2014-02-28 | 89.05K ILS 10-Q · filed 2014-04-10 |
USD
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2021-02-28 | $135.00K 10-Q · filed 2021-04-13 |
| 2020-11-30 | $134.00K 10-Q · filed 2021-01-14 |
| 2014-05-31 | $25.63K 10-Q · filed 2014-07-14 |
| 2014-02-28 | $25.42K 10-Q · filed 2014-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |